Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Foreclosures fueled racial segregation in U.S., study finds

  • Brain chemical may offer new clues in treating chronic pain

  • New study calls for changes to childcare 'mandatory' sleep rules in daycare

  • Carrot or stick? Punishments may guide behavior more effectively than rewards

  • The most important psychological concepts for teachers to apply in classrooms

  • Non-Euclidean geometries for grid cells

  • First evolutionary history of 50 years of music charts using big data analysis of sounds

  • We all want high social status

  • 'Dr. Google' doesn't know best: Search engine self-diagnosis and 'cyberchondria'

  • Children's sleep, mental health are related

  •